Note de episod
Most cancers are caught too late, and Ryuichi Onose has spent the last seven years trying to change that.
His company, Craif, can detect 10 of the most common cancers from a urine sample, before symptoms, before scans can even see anything. Their accuracy for stage one pancreatic cancer sits at 93%, compared to 37% for the standard blood marker test.
Ryuichi was 26 and managing ships at Mitsubishi when his grandmother died of stage four colorectal cancer in three weeks. He had no biotech background. He left anyway. Now Craif has sold over 50,000 tests across 2,000 hospitals and 4,600…
Site: podcasters.spotify.com

